About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals is a company based in Mumbai (India) founded in 1977. The company has 16,620 employees as of March 31, 2024. Glenmark Pharmaceuticals offers products and services including Pharmaceutical Formulations and Therapy Areas Products. Glenmark Pharmaceuticals operates in a competitive market with competitors including Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
- Headquarter Mumbai, India
- Employees 16620 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Glenmark Pharmaceuticals Limited
-
Annual Revenue
$1.56 B (USD)12.77as on Mar 31, 2025
-
Net Profit
$122.55 M (USD)0as on Mar 31, 2025
-
EBITDA
$278.81 M (USD)93.33as on Mar 31, 2025
-
Latest Funding Round
$200 M (USD), Debt – Conventional
Sep 28, 2019
-
Investors
Not available
-
Employee Count
16620
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Glenmark Pharmaceuticals
Glenmark Pharmaceuticals is a publicly listed company on the NSE with ticker symbol GLENMARK in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Glenmark Pharmaceuticals
Glenmark Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Therapy Areas Products.
Develops and produces formulations for therapy areas like oncology
Focuses on innovative therapies in dermatology and respiratory
People of Glenmark Pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Glenmark Pharmaceuticals
Investments & Acquisitions by Glenmark Pharmaceuticals
Investment portfolio details for Glenmark Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Glenmark Pharmaceuticals
Detailed financials for Glenmark Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Glenmark Pharmaceuticals Comparisons
Peer comparison for Glenmark Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Glenmark Pharmaceuticals
Glenmark Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| Locked | Locked | Locked |
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
Detailed competitors of Glenmark Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glenmark Pharmaceuticals
Complete news archive for Glenmark Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glenmark Pharmaceuticals
Glenmark Pharmaceuticals was founded in 1977 and raised its 1st funding round 42 years after it was founded.
Glenmark Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at Glenmark Pharmaceuticals is 16,620.
Annual revenue of Glenmark Pharmaceuticals is $1.56B as on Mar 31, 2025.
Glenmark Pharmaceuticals was founded in 1977 and is headquartered in Mumbai, India. Operations are centered on research and development, with a focus on manufacturing generic drugs across various therapeutic areas. The company serves global markets by producing affordable medications for conditions including dermatology, respiratory, and cardiovascular disorders. Leadership is provided by Managing Director Glenn Saldanha, overseeing strategic initiatives in the pharmaceutical sector.
Glenmark Pharmaceuticals's top competitors include Merck, Roivant Sciences and Amgen.
Glenmark Pharmaceuticals offers Pharmaceutical Formulations and Therapy Areas Products.
Yes, Glenmark Pharmaceuticals is publicly traded on NSE under the ticker symbol GLENMARK.
The ticker symbol of Glenmark Pharmaceuticals is GLENMARK on NSE.